303 related articles for article (PubMed ID: 35972133)
1. Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model.
Varga JJ; Zhao CY; Davis JD; Hao Y; Farrell JM; Gurney JR; Voit E; Brown SP
mSphere; 2022 Oct; 7(5):e0031822. PubMed ID: 35972133
[TBL] [Abstract][Full Text] [Related]
2. Lung function and microbiota diversity in cystic fibrosis.
Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
[TBL] [Abstract][Full Text] [Related]
4. High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.
Raghuvanshi R; Vasco K; Vázquez-Baeza Y; Jiang L; Morton JT; Li D; Gonzalez A; DeRight Goldasich L; Humphrey G; Ackermann G; Swafford AD; Conrad D; Knight R; Dorrestein PC; Quinn RA
mSystems; 2020 Jun; 5(3):. PubMed ID: 32576651
[TBL] [Abstract][Full Text] [Related]
5. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
6. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens.
Vandeplassche E; Tavernier S; Coenye T; Crabbé A
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285289
[TBL] [Abstract][Full Text] [Related]
7. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
[TBL] [Abstract][Full Text] [Related]
8. Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis.
Vieira J; Jesudasen S; Bringhurst L; Sui HY; McIver L; Whiteson K; Hanselmann K; O'Toole GA; Richards CJ; Sicilian L; Neuringer I; Lai PS
mSystems; 2022 Oct; 7(5):e0036422. PubMed ID: 36000724
[TBL] [Abstract][Full Text] [Related]
9. Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.
Quinn RA; Lim YW; Maughan H; Conrad D; Rohwer F; Whiteson KL
mBio; 2014 Mar; 5(2):e00956-13. PubMed ID: 24643867
[TBL] [Abstract][Full Text] [Related]
10. Defining the Benefits of Antibiotic Resistance in Commensals and the Scope for Resistance Optimization.
Wollein Waldetoft K; Sundius S; Kuske R; Brown SP
mBio; 2023 Feb; 14(1):e0134922. PubMed ID: 36475750
[TBL] [Abstract][Full Text] [Related]
11. Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.
Boutin S; Graeber SY; Weitnauer M; Panitz J; Stahl M; Clausznitzer D; Kaderali L; Einarsson G; Tunney MM; Elborn JS; Mall MA; Dalpke AH
PLoS One; 2015; 10(1):e0116029. PubMed ID: 25629612
[TBL] [Abstract][Full Text] [Related]
12. Data Mining of Lung Microbiota in Cystic Fibrosis Patients.
Li J; Hao C; Ren L; Xiao Y; Wang J; Qin X
PLoS One; 2016; 11(10):e0164510. PubMed ID: 27741283
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an
Harrington NE; Littler JL; Harrison F
Appl Environ Microbiol; 2022 Feb; 88(3):e0178921. PubMed ID: 34878811
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
Caverly LJ; Zhao J; LiPuma JJ
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
[TBL] [Abstract][Full Text] [Related]
15. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.
Magalhães AP; Azevedo NF; Pereira MO; Lopes SP
Appl Microbiol Biotechnol; 2016 Feb; 100(3):1163-1181. PubMed ID: 26637419
[TBL] [Abstract][Full Text] [Related]
16. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
[TBL] [Abstract][Full Text] [Related]
18. Resilience and stability of the CF- intestinal and respiratory microbiome during nutritional and exercise intervention.
Knoll RL; Jarquín-Díaz VH; Klopp J; Kemper A; Hilbert K; Hillen B; Pfirrmann D; Simon P; Bähner V; Nitsche O; Gehring S; Markó L; Forslund SK; Poplawska K
BMC Microbiol; 2023 Feb; 23(1):44. PubMed ID: 36803565
[TBL] [Abstract][Full Text] [Related]
19. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominance.
Henson MA; Orazi G; Phalak P; O'Toole GA
mSystems; 2019; 4(2):. PubMed ID: 31020043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
